BMO
SHC icon

Beck Mack & Oliver’s Sotera Health SHC Stock Holding History

Beck Mack & Oliver’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.81M Buy
+552,450
New +$8.71M 0.19% 54

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Beck Mack & Oliver's SHC Position: Q2 2026 in Review

Beck Mack & Oliver opened a new position in Sotera Health (SHC) in Q2 2026: 552,450 shares worth $9.81M. The stake represents 0.19% of the portfolio and ranks #54 among its holdings.

316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Beck Mack & Oliver held 552,450 shares of Sotera Health worth $9.81M as of Q2 2026.
  • Sotera Health was a new Beck Mack & Oliver position in Q2 2026.
  • Sotera Health made up 0.19% of Beck Mack & Oliver's portfolio in Q2 2026, its #54 holding.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.